Yang et al. reported that triptolide exerted a therapeutic role in cerulein-induced AP by activating the expression of Nrf2 and HO-1 in vivo and in vitro (Yang et al., 2022). This evidence concerns the gene HMOX1 and alkaline phosphatase measurement.